Rights Upheld
Upholding Minority Shareholder Rights in a Pharmaceutical Dispute
Rights Upheld
Upholding Minority Shareholder Rights in a Pharmaceutical Dispute
Key Contacts
After an unlawful sale, how do you assess the true value of a business?
In a bitterly fought suit, the minority shareholders of a manufacturer and distributor of a novel medication that relieves pain and treats cerebrovascular diseases in China commenced derivative actions for breach of duties against the directors of the company, claiming they had carried out a fraud in selling the company’s assets to the Chairman at a gross undervalue. The British Virgin Islands (“BVI”) Commercial Court had already handed down judgment on liability in favor of the minority shareholders and against the directors. FTI Consulting was engaged to determine the compensation that the minority shareholders were owed.
Our Impact
Our Role
Managing material information gaps with a pragmatic and transparent approach
FTI Consulting provided critical expert testimony and valuation services, helping to secure a favorable outcome for minority shareholders in a high-stakes pharmaceutical business dispute.
FTI Consulting conducted a complex valuation despite incomplete disclosures from defendants.
The team prepared a detailed expert report on business growth prospects and risks as well as various potential valuation reference points to help determine the value of the business when it was sold.
FTI Consulting testified at the trial on quantum and relief, where the court fully accepted Ben Johnson’s expert evidence, valuing the business conservatively at HKD441 million at the time of sale.
Related Experts
Discover Your Team
Real-world experience that delivers.
See why FTI Consulting is the leading global expert firm for organisations facing crisis and transformation.
More Success Stories
Deep Expertise in Action
See how our expert-driven, industry-focused approach produces real results in an increasingly complex world.
